|Study outcomes||Research questions||Measurement|
|Effectiveness||Will iSOLVE be effective in reducing falls in patients of participating practices compared to control practices?||Falls over 12 months—recorded daily on monthly calendars|
|Will iSOLVE increase general practitioners’ engagement in fall prevention management and referral practices compared to the control GPs?||Pre-post survey of GPs in trial—management of fall prevention and any changes in practice (Q11: frequency of risk factor assessment, medication review, advice); referral patterns (Q12: frequency of referral and to whom); knowledge of fall prevention services.|
|Will iSOLVE be effective in reducing burden of drug risk and polypharmacy in use of drugs associated with falls in patients of participating practices compared to control practices?||Drug Burden Index; Falls Risk Increasing Drugs (FRID); Changes in polypharmacy and in use of drugs associated with falls (e.g., psychotropics).|
|Will iSOLVE be cost effective from a healthcare funder perspective, and expressed as an incremental cost per fall avoided?||Falls and Health care utilization—monthly calendars intervention costs—staff, training, capital costs, consumables.|
|Will patients in the intervention group report significantly higher interaction with their GP about fall prevention and engagement in fall prevention activities compared to the control group?||Pre-post patient survey.|
How are the iSOLVE strategies adopted (or not) by general practitioners (GPs), by Allied health professional’s (AHP)), and by the primary care network?|
How does this change practice in fall prevention?
How does this influence the nature of pathways for identifying older people at risk and managing fall risk within primary care?
|In-depth interviews with a sample of the participating trial GPs, AHPs participating in the workshops and with key coordinating stakeholders, such as Primary Care Network staff|
|What are the factors that facilitate embedding of the intervention in usual care?||
In-depth interviews as above|
Meeting minutes, observations, and field notes.
AHP planning strategies document from the workshops.
|What factors will influence sustainability of training and knowledge translation for GPs, AHPs and community pharmacist?||
In-depth interviews of GPs and AHPs as above|
Pre- and post surveys of AHPs who participate in the workshops
AHP planning strategies document from the workshops
|What is the GPs professional network in relation to fall prevention and who is influential within their network?||Relational network (who and influence) questions in survey for trial GPs. Network influence question in AHPs survey and in the ecological survey of GPs in geographical area of SNPHN|
|How effective is iSOLVE dissemination across the SNPHN network?||Geographical survey of GPs in SNPHN|